SEC Form 4 · accession 0001645627-19-000003
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Jan 9, 2019
Accepted (ET)
Jan 15, 2019 · 5:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 9, 2019 | P | 1,000 | $0.019 | A | 26,669,897 | D | |
| Common Stock | Jan 9, 2019 | P | 2,000 | $0.019 | A | 26,671,897 | D | |
| Common Stock | Jan 10, 2019 | P | 1,000 | $0.0186 | A | 26,672,897 | D | |
| Common Stock | Jan 10, 2019 | P | 2,000 | $0.019 | A | 26,674,897 | D | |
| Common Stock | Jan 10, 2019 | P | 1,000 | $0.0186 | A | 26,675,897 | D | |
| Common Stock | Jan 10, 2019 | P | 2,000 | $0.0189 | A | 26,677,897 | D | |
| Common Stock | Jan 11, 2019 | P | 2,000 | $0.0276 | A | 26,679,897 | D | |
| Common Stock | Jan 11, 2019 | P | 2,000 | $0.0258 | A | 26,681,897 | D | |
| Common Stock | Jan 11, 2019 | P | 2,000 | $0.0257 | A | 26,683,897 | D | |
| Common Stock | Jan 11, 2019 | P | 2,000 | $0.0255 | A | 26,685,897 | D | |
| Common Stock | Jan 11, 2019 | P | 2,000 | $0.0273 | A | 26,687,897 | D | |
| Common Stock | Jan 15, 2019 | P | 2,000 | $0.0319 | A | 26,689,897 | D |
Table II — derivative securities
No Table II lines on this filing.